PMID int64 35.7M 36.4M | Title/Abstract stringlengths 22 8.78k | MeshTerms stringlengths 7 101 | SemanticTypes stringlengths 4 64 |
|---|---|---|---|
36,309,515 | flexibl hyperspectr surfac plasmon reson microscopi optic techniqu visual quantif chemic biolog analyt alway high desir show hyperspectr surfac plasmon reson microscopi hsprm system use hyperspectr microscop analyz select area spr imag produc prism base spectral spr sensor hsprm system enabl monochromat polychromat spr... | D020349;D006108 | T063;T196;T109 |
36,309,514 | administr broad neutral anti hiv antibodi art initi maintain long term cd cell immun simian human immunodefici virus shiv infect non human primat broad neutral antibodi bnab virus appear stimul cell immun determin whether phenomenon also occur human measur hiv specif cellular immun longitudin individu hiv start antivir... | D016097;D015302;D015497;D015658 | T047;T005 |
36,309,512 | natur scene sampl reveal reliabl coars scale orient tune human v orient select primat visual cortex organ cortic column sinc cortic column finer spatial scale sampl resolut standard bold fmri measur analysi approach propos peer past spatial resolut limit recent found method predomin sensit stimulus vignet form select a... | D001931;D014793 | T062;T060;T029;T023 |
36,309,511 | biomimet lamin strategi enabl strain interfer free durabl flexibl thermistor electron develop flexibl thermistor epiderm electron ftee satisfi high temperatur resolut without strain induc signal distort great signific still challeng inspir nacr microstructur capabl restrain stress concentr exemplifi versatil mxene base... | D060734 | T109 |
36,309,510 | cellular glycan modif bgat broad restrict influenza virus infect communic respiratori viral infect pose epidem pandem threat broad spectrum antivir strategi could improv prepared event discov host antivir restrict factor may act suitabl target develop host direct antivir therapi conduct whole genom crispr activ screen ... | D007251;D053118;D009976 | T047;T005 |
36,309,507 | trace intern arriv sar cov omicron variant aotearoa new zealand reopen border second quarter global surg emerg sar cov lineag distinct growth advantag domin omicron ba ba lineag generat omicron genom show aotearoa new zealand observ influx immun evas variant ba ba ba border explain return signific level intern travel f... | D000086402;D000086382 | T005;T067;T047 |
36,309,506 | proteo genom character virus associ liver cancer reveal potenti subtyp therapeut target primari liver cancer heterogen diseas term etiolog histolog therapeut respons concurr proteom genom character larg set clinic liver cancer sampl help elucid molecular basi heterogen thus serv valuabl resourc person liver cancer trea... | D040901;D008113 | T191;T091 |
36,309,502 | autom identif sequenc tailor cas protein use massiv metagenom data identif protospac adjac motif pam sequenc cas nucleas crucial exploit genom edit develop comput pipelin use interrog massiv expand dataset metagenom virom assembl accur comprehens pam predict procedur allow identif isol sequenc tailor cas nucleas use ta... | D000076987;D064113 | T040;T126;T116 |
36,309,500 | multipl sourc aerob methan product aquat ecosystem includ bacteri photosynthesi aquat ecosystem global signific sourc greenhous gas methan atmospher recent methan product thought strict anaerob process confin primarili anox sediment howev supersatur methan oxygen water consist observ lake ocean term methan paradox indi... | D017753;D060106 | T083;T070;T082 |
36,309,499 | isotrop reconstruct electron tomographi deep learn cryogen electron tomographi cryoet allow visual cellular structur situ howev anisotrop resolut aris intrins miss wedg problem present major challeng visual interpret tomogram develop isonet deep learn base softwar packag iter reconstruct miss wedg inform increas signal... | D055032;D000077321 | T059;T066 |
36,309,498 | genom wide rare variant score associ morpholog subtyp autism spectrum disord defin differ genet subtyp autism spectrum disord asd enabl predict development outcom base minor physic major congenit anomali categor canadian children asd dysmorph nondysmorph subgroup develop method calcul patient level genom wide rare vari... | D000067877 | T048 |
36,309,497 | structur insight light driven anion pump cyanobacteria transmembran ion transport key process live cell activ transport ion carri various ion transport includ microbi rhodopsin mrs mrs perform divers function activ passiv ion transport photo sens other particular mrs pump various monoval ion like na k cl character mr p... | D027321;D046939 | T123;T007;T116 |
36,309,495 | neuron camkk promot immunosuppress checkpoint blockad resist glioblastoma glioblastoma gbm notori immunosuppress tumor microenviron tme refractori immun checkpoint blockad icb identifi calmodulin depend kinas kinas camkk driver icb resist camkk high express pro tumor cell associ worsen surviv patient gbm host camkk spe... | D005909 | T191 |
36,309,493 | compet instabl reveal ration design control activ crosslink gel activ stress generat molecular motor set larg scale mechan cell cytoskeleton remain poor understood combin experi theori demonstr emerg properti biomimet activ crosslink gel depend properti microscop constitu show extensil nemat elastom exhibit two distinc... | D003599;D008870 | T026 |
36,309,492 | differenti traffick ligand trogocytos via cd versus ctla promot collect cellular control co stimul intercellular communic crucial collect regul cellular behavior cluster cell shown mutual control product key communic signal unclear whether also joint regul avail degrad use newli develop report system bioinformat analys... | D018106;D018796 | T129;T121;T116;T192 |
36,309,491 | impact phosphorus project sub saharan africa food secur futur sub saharan africa must urgent improv food secur phosphorus avail one major barrier due low histor agricultur use share socioeconom pathway ssps indic sustain ssp fossil fuell futur ssp improv food secur term price avail risk hunger whilst nationalist ssp un... | D010758;D000383 | T090;T196;T197 |
36,309,490 | analysi anti sar cov omicron neutral antibodi titer differ vaccin unvaccin convalesc plasma sourc latest sar cov variant concern omicron immun escap therapeut anti spike monoclon antibodi wa vaccin elicit sera demonstr continu relev covid convalesc plasma ccp therapi lesson learnt previous usag ccp suggest focus earli ... | D000086402;D000086382 | T005;T067;T047 |
36,309,488 | adher impact home base high intens imt peopl spinal cord injuri pilot studi pilot studi complet phase control phase imt incorpor assess baselin bl bl follow f f f f | D001945;D013119 | T061;T037 |
36,309,487 | inhibit cd traf depend inflammatori activ halt onset diabet retinopathi streptozotocin diabet mice diabet initi inflamm impair retin vasculatur lead diabet retinopathi one lead caus blind inflammatori pathway examin potenti therapeut target diabet retinopathi still need earli stage treatment hypothes cd tnf receptor as... | D003921;D003930 | T047;T050 |
36,309,486 | desmoglein import islet function cell surviv type diabet complex diseas character lack endogen insulin secret pancreat cell although cell target autoimmun process cell dysfunct known occur type diabet complet understand cell cell interact support pancreat function still lack character pancreat endocrin compart studi pa... | D003921;D003922;D007515 | T047;T050;T023 |
36,309,484 | egfl drive evolut resist egfr inhibitor lung cancer activ notch signal accumul evid support evolutionari trait drug resist like resili system tumor cell experi drug toler state full resist acquir howev under mechan still poor understood identifi egf like domain multipl egfl respons gene epiderm growth factor receptor e... | D016228;D008175 | T123;T191;T116 |
36,309,483 | polygen heterogen antidepress treatment placebo respons genet architectur antidepress respons poor understood polygen risk score prs explor placebo respons use sub scale might provid insight investig associ prss relev complex trait respons vortioxetin treatment placebo use clinic scale includ sub scale self report asse... | D003865 | T048 |
36,309,482 | bromodomain contain protein brd epigenet regul fatti acid metabol gene ferroptosi reprogram lipid metabol consid fundament step tumourigenesi influenc ferroptosi howev molecular mechan lipid metabol ferroptosi remain larg unknown result drug screen inhibitor target appli ferroptosi cell indic inhibitor target bromodoma... | D000079403 | T043 |
36,309,470 | evalu microleakag push bond strength various composit resin seal screw access channel implant support restor microleakag loss composit resin seal screw access channel frequent complic screw retain implant support prosthes screw access channel best restor reduc complic unclear | D003763;D015921 | T046;T074 |
36,309,469 | comparison accuraci impress made implant interf axial converg cad cam impress cope alter cast techniqu vitro studi studi evalu accuraci differ method make impress implant close proxim advers axial converg lack | D003761;D015921 | T061;T074 |
36,309,468 | individu variat distanc nasion frankfort horizont plane error factor facebow semi adjust articul semi adjust articul use averag axi facebow nasion relat fix distanc mm mm orbital anterior refer point locat axi orbit plane major factor measur sagitt condylar inclin later cephalometr radiograph allow measur distanc nasio... | D003725;D005145 | T074;T029 |
36,309,467 | innov fix prosthodont workflow systemat approach treat complet mouth reconstruct essenti achiev optim treatment result current convent method alway provid fulli control set util digit ecosystem allow creat predict effici workflow fix prosthodont reconstruct | D017076;D011476 | T091;T066 |
36,309,462 | five patient spinal muscular atrophi progress myoclon epilepsi sma pme novel pathogen variant treatment review literatur spinal muscular atrophi progress myoclon epilepsi sma pme rare inherit autosom recess diseas due bi allel mutat asah gene sma pme character progress muscl weak three seven year age accompani epilepsi... | D020191;D009134;D016472 | T047 |
36,309,459 | melissa officinali essenti oil antimicrobi agent listeria monocytogen watermelon juic burden foodborn ill negat effect public health also countri economi melissa officinali aromat plant known biolog properti includ antioxid antimicrobi effect work highlight officinali essenti oil antioxid potenti antimicrobi activ l mo... | D008089;D009822;D031334;D029773;D000890 | T121;T007;T109;T168;T002 |
36,309,458 | chameleon like microb promot microecolog differenti daqu chameleon like microb ferment communiti intern factor facilit transform communiti correspond homeostasi state specif environment condit high temperatur daqu form three typic microecolog prepar process make ideal system studi chameleon like microb studi integr mul... | D001419;D059013 | T007;T001 |
36,309,457 | penicillium digitatum antifung protein pdafpb show high activ mycobiota involv slice bread spoilag studi aim isol identifi fungal speci involv slice bread spoilag evalu suscept antifung protein fungal origin afp protein includ pdafpb penicillium digitatum peafpa peafpb peafpc penicillium expansum base morpholog criteri... | D001939;D010407 | T168;T004 |
36,309,456 | combin treatment polylysin heat damag protect structur spore inner membran inactiv bacillus subtili spore steril effect combin heat c polylysin pl gl treatment bacillus subtili spore investig compar convent heat steril inactiv rate spore chang protect structur evalu use differ method techniqu chang cell membran fatti a... | D001412;D009696 | T123;T007;T114 |
36,309,455 | develop applic multiplex pcr method differenti salmonella enterica serovar typhimurium monophas variant pig farm salmonella enterica serovar typhimurium monophas variant salmonella increas dramat caus human salmonellosi colon pig differ typhimurium monophas variant typhimurium lose gene cassett encod second phase flage... | D012480;D019779 | T047;T007 |
36,309,454 | protect role acinetobact bacillus escherichia coli h biofilm sodium hypochlorit extracellular matrix degrad enzym foodborn pathogen bacteria multi speci biofilm food manufactur facil suspect caus cross contamin lead foodborn ill studi cafeteria kitchen associ bacteri isol protect effect e coli h biofilm extracellular p... | D019453;D000150;D001407;D005517 | T007;T037 |
36,309,453 | applic natamycin farnesol bioprotect agent inhibit biofilm format yeast foodborn bacteri pathogen appl juic process line biofilm serv reservoir pathogen spoilag microorgan remov differ surfac recur problem beverag industri studi aim investig effect combin natamycin nat mmoll farnesol far mmoll biofilm ultrafiltr uf mem... | D027845;D019453;D008089 | T168;T007;T002 |
36,309,452 | rapid detect listeria monocytogen dairi product novel chemilumonogen approach routin monitor foodborn pathogen listeria monocytogen food process environ time consum necess ensur food safeti altern rapid diagnost method pathogen detect increas use often demand special equip make unsuit site test short communic describ s... | D008089 | T007 |
36,309,451 | cross contamin escherichia coli h listeria monocytogen viabl non cultur vbnc state wash leafi green reviv shelf life water disinfect treatment chlorin chlorin dioxid use fresh cut industri maintain microbiolog qualiti process water pw inactiv bacteri cell water also lead induct intermedi state viabl non viabl known via... | D019453;D008089 | T007 |
36,309,450 | character microbi communiti assembl new wooden vat use chees product wooden vat use product tradit chees biofilm wooden vat surfac known transfer larg quantiti microb chees howev studi investig microbi composit biofilm newli develop wooden vat communiti assembl evolv present studi microbi communiti biofilm character ac... | D002611;D064307 | T001;T168;T032;T028 |
36,309,449 | non redund natur lactiplantibacillus plantarum plasmidom reveal compar genom analysi strain lactiplantibacillus plantarum homofer lactic acid bacterium lab often found ferment food mani strain display probiot properti strain belong l plantarum stress toler metabol flexibl lactobacilli display larger genom higher plasmi... | D019936;D048191 | T007 |
36,309,448 | role siderophor pseudomona fluorescen biofilm format spoilag potenti function investig function pyoverdin biofilm format motil spoilag potenti pseudomona fluorescen target identifi two major gene pvda pvde involv biosynthesi siderophor next construct pvda pvde mutant p fluorescen pf found delet pyoverdin led biofilm mo... | D017262;D011551 | T123;T007;T109 |
36,309,447 | chang resistom profil potenti probiot lactiplantibacillus pentosus respons edibl oil adapt despit increas interest investig horizont gene transfer lead caus antibiot resist spread resistom influenc influx efflux gene differ environ rather express exist gene differ stress condit requir special attent studi determin whet... | D000070018;D019936;D031658 | T168;T007;T002 |
36,309,446 | cold toler microorgan caus spoilag vacuum pack beef time temperatur abus determin cultur qpcr vacuum packag storag condit chill temperatur common use order prolong shelf life meat condit time temperatur abus cold toler facult anaerob spoilag microorgan continu grow studi investig growth six relev spoilag microorgan vac... | D018857;D005506 | T068;T073;T067 |
36,309,445 | candida krusei major contamin ultrafiltr revers osmosi membran use cranberri juic product ultrafiltr uf revers osmosi ro common use clarif concentr fruit juic howev one main limit filtrat membran biofoul reduc membran effici contamin filter product lead spoilag studi microbi foul layer uf ro membran canadian cranberri ... | D014462;D029799 | T061;T168;T002 |
36,309,444 | growth food born pathogen listeria salmonella spore form paenibacillus bacillus commerci plant base milk altern object present studi compar growth food pathogen listeria monocytogen salmonella enterica food spoilag bacillus subtili industri milk product isol spore form paenibacillus commerci avail ultrahigh temperatur ... | D056507;D001407;D008087;D008089 | T007 |
36,309,443 | plant base natur flavonoid show strong inhibit aflatoxin product relat gene express correl chemic structur aflatoxin strong carcinogen mutagen fungal metabolit aflatoxin contamin critic issu agricultur food product natur flavonoid suppress aflatoxin biosynthesi howev structur activ relationship remain unclear present s... | D000348 | T131;T109 |
36,309,442 | systemat review meta analysi indic substanti burden human norovirus shellfish worldwid gii gii predomin genotyp human norovirus hunov found lead caus acut gastroenter outbreak age group signific correl consumpt shellfish studi contamin hunov shellfish estim systemat review meta analysi studi contamin hunov shellfish se... | D029322;D010125;D005759;D049872;D017250 | T005;T204;T047 |
36,309,441 | high pressur process control salmonella raw pet food without compromis fresh appear impact acidul frozen storag trend feed dog cat raw pet food claim health benefit pose health concern due occurr pathogen bacteria high pressur process hpp allow non thermal inactiv microorgan preserv nutrit characterist minim impact org... | D002371;D004283 | T047 |
36,309,440 | bacteri communiti develop divers first year product new salmon process plant bacteri divers load equip food process facil constant influenc raw materi water air staff despit regular clean disinfect bacteria may persist therebi potenti compromis food qualiti safeti littl known bacteri communiti new food process facil gr... | D005516;D012474 | T067;T013 |
36,309,439 | acid shock protein asr induc protein aggreg promot e coli h enter viabl non cultur state high pressur carbon dioxid stress stress condit bacteria enter viabl non cultur vbnc state surviv vbnc cell lost abil grow routin cultur medium still aliv may reviv suitabl condit reviv cell consum nutrient produc toxin lead food s... | D019453 | T007 |
36,309,438 | applic enterocin whey film reduc listeria monocytogen contamin ripen chees enterocin whey solut obtain grow enterococcus faecali lbk lak sweet whey enterocin whey solut ew incorpor gelatinglycerol film test control listeria monocytogen film contain enterocin produc either strain ew l ew k film shown serv suitabl matrix... | D008089;D002611;D001430 | T168;T007;T123;T116 |
36,309,437 | induct viabl noncultur salmonella spp liquid egg mild heat subsequ resuscit salmonella spp one lead caus foodborn outbreak worldwid salmonella spp associ varieti food sourc particular egg product enter viabl noncultur vbnc state respons harsh stress vbnc cell still retain membran integr metabol activ may pose health ri... | D006358;D019779 | T070;T007 |
36,309,436 | solubl extracellular polymer substanc sep histo blood group antigen hbga express bacterium sphingobacterium sp sc influenc surviv persist norovirus lettuc foodborn norovirus nov outbreak link leafi green common due lack effici strategi prevent nov spread contamin surfac previous found sphingobacterium sp sc lettuc phyl... | D029322;D001789;D045249 | T185;T129;T005;T007 |
36,309,435 | character polysulfid saccharomyc cerevisia cell finish wine cystein supplement model grape medium polysulfid degrad wine result hydrogen sulfid h releas impart rotten egg smell detriment wine qualiti although presenc wine polysulfid demonstr biogenesi remain unclear studi investig role saccharomyc cerevisia polysulfid ... | D014920;D027843 | T129;T168;T116;T002 |
36,309,434 | meat deriv escherichia coli pseudomona fragi manag co exist dual speci biofilm adjust gene regul competit strength pseudomona fragi escherichia coli consid common colon fresh spoilag meat tend live proxim studi primarili test interplay pattern differ isol two speci two two combin grown stainless steel surfac dual speci... | D044206 | T007 |
36,309,433 | evalu influenc oper paramet puls light wine relat yeast focus inter intra specif variabl sensit oenolog grow demand consum wine produc less input sulphit frequent use microbi control emerg control method manag microorgan wine wide studi studi effici puls light pl treatment investig drop plat system use evalu impact thr... | D014920;D055168 | T168;T004 |
36,309,432 | multipl region high resolut melt base method accur differenti food deriv yeast speci level resolut yeast compris diverg group microorgan play import role food product monitor product process valid authent safeti food reliabl method yeast identif differenti need nowaday tradit pcrsequenc base method replac rapid techniq... | D015003;D004718 | T004 |
36,309,431 | tio base photocatalyst generat reactiv oxygen speci caus cell membran disrupt staphylococcus aureus escherichia coli h photocatalyst includ titanium dioxid tio attract much attent food safeti control foodborn pathogen howev studi photocatalyt activ various food surround media factor affect efficaci photocatalyt inactiv... | D019453;D013203 | T047;T007 |
36,309,430 | warm climat ventil indoor temperatur outdoor relat humid signific effect campylobact spp colon chicken broiler farm occur day longitudin studi conduct five convent broiler farm year period determin dynam campylobact infect warm climat region north eastern spain week sampl flock perform upon one day old chick placement ... | D002169;D011201;D002167 | T047;T007 |
36,309,429 | depth multiphas analysi chocol product chain bean bar demonstr superior saccharomyc cerevisia hanseniaspora opuntia function starter cultur cocoa ferment hanseniaspora opuntia common found yeast speci natur ferment cocoa pulp bean mass need depth investig present studi aim examin effect cocoa isol h opuntia imdo part t... | D000069956;D055549;D002099;D007887 | T168;T002;T109 |
36,309,428 | quantif hepat e virus raw pork liver use droplet digit rt pcr hepat e virus hev causat agent hepat e rise hepat e infect china may link undercook pork studi establish revers transcript droplet digit pcr rt ddpcr method detect hev raw pork liver detect limit assay hev rna low copiesl suggest approach valid sampl demonst... | D016752;D016751;D000080305;D000069466;D013553 | T168;T005;T047 |
36,309,427 | preval campylobact speci associ risk factor contamin dairi product collect dri season major milk shed ethiopia cross section studi conduct investig preval risk factor contamin ethiopian dairi product campylobact total dairi food sampl collect establish studi particip interview sampl test campylobact follow iso standard... | D002167;D016123 | T007 |
36,309,426 | marin increas tyramin level rainbow trout fillet strip packag modifi atmospher marinad increas use manufactur raw fish product correspond meat marin known major effect composit microbiom effect marin fish known well knowledg gap prompt studi microbi ecolog amin format marin unmarin modifi atmospher commerci packag rain... | D017686 | T013 |
36,309,424 | prostat endocrin organ modul serum testosteron asid nonmelanoma skin cancer prostat cancer common cancer among men unit state benign prostat hyperplasia common benign tumor found men recent endocrin function possibl influenc hypothalam pituitari axi relat understudi review summar current understand potenti endocrin fun... | D011470;D011471 | T047;T191 |
36,309,423 | testosteron replac option treatment male hypogonad complic multitud treatment avail lack clear understand differ treatment modal barrier treatment patient mispercept unrealist expect anxieti articl intend help practition better understand challeng testosteron replac option order better counsel treat patient hypogonad | D013739;D007006 | T125;T121;T047;T109 |
36,309,422 | testosteron assay challeng accur precis measur testosteron includ defici standard variabl refer rang expens relat gold standard equip challeng total testosteron remain access standard laboratori free testosteron bioavail testosteron may use adjunct particular men low borderlin testosteron valu mass spectrometri gold st... | D013739;D007006 | T125;T121;T047;T109 |
36,309,421 | androgen steroid use abus past present futur androgen steroid abus elit athlet decad perform enhanc properti sport involv strength power confirm class ban elit athlet competit sinc mid risk withdraw syndrom includ sever depress seem increas risk cardiovascular diseas associ chronic abus contrast high dosag androgen abu... | D045930;D004300 | T121;T039;T052 |
36,309,420 | learn testosteron trial men age serum concentr total testosteron decreas slight concentr sex hormon bind globulin increas concentr free testosteron decreas greater degre testosteron trial demonstr testosteron treatment elder men low serum testosteron level increas sexual function hemoglobin bone miner densiti moder deg... | D013739;D007006 | T125;T121;T047;T109 |
36,309,419 | testosteron male sexual function articl review role testosteron normal male sexual anatom develop function consequ low testosteron sexual function clinic standard health care provid treat hypogonad men sexual dysfunct | D007172;D012735 | T047;T046 |
36,309,418 | molecular mechan castrat resist prostat cancer despit newer therapi castrat resist prostat cancer crpc mani patient experi treatment respons eventu experi secondari resist various androgen receptor relat altern mechan resist crpc identifi focus understand molecular basi therapeut resist includ lineag plastic neuroendoc... | D064129 | T191 |
36,309,417 | testosteron androgen receptor testosteron steroid hormon respons develop normal male sexual characterist function well mainten homeostasi among multipl organ system throughout life testosteron product regul hypothalam pituitari axi direct gonadotropin releas hormon lutein hormon testosteron bound androgen receptor ar p... | D013739;D011944 | T121;T116;T192;T109;T125 |
36,309,416 | benefit risk testosteron treatment older men hypogonad total free testosteron level declin men advanc age due defect level hypothalam pituitari testicular axi testosteron treatment older men low testosteron level associ improv sexual activ sexual desir erectil function lean bodi mass muscl strength stair climb power se... | D007006;D011471 | T047;T191 |
36,309,415 | current manag controversi surround andropaus andropaus condit surround controversi whether diagnosi manag learn pathophysiolog hypogonad perspect risk benefit testosteron therapi shift attempt discuss modern relev point controversi current affect field throughout review discuss art diagnos hypogonad well associ lack th... | D047649;D007006;D011471 | T033;T047;T191 |
36,309,414 | testosteron therapi prostat cancer incorpor low level evid practic recommend wide accept absolut contraind administr testosteron hypogonad men prostat cancer question although recommend profession associ still adher tradit concept increas relax posit current evid definit guidelin unavail clinician reli incomplet best a... | D011471;D007006 | T047;T191 |
36,309,413 | inexor march prostat cancer research testosteron beyond histori prostat cancer treatment fill progress past year understand role testosteron genesi prostat cancer continu evolv diagnost test treatment local metastat prostat cancer undergon major chang recent decad transform outlook patient prostat cancer articl review ... | D013739;D011471 | T125;T121;T191;T109 |
36,309,410 | associ fibromyalgia syndrom clinic sever bodi composit princip compon analysi type bodi composit modul sever musculoskelet condit fibromyalgia syndrom fms type associ remain relat unexplor | D005356 | T047 |
36,309,409 | real world effect safeti jak inhibitor rheumatoid arthriti singl centr studi assess effect safeti baricitinib tofacitinib rheumatoid arthriti ra patient real world condit | D000075242;D018501;D001172 | T121;T047 |
36,309,406 | poor prognosi intraves bacillus calmett gurin histori photodynam diagnosi assist transurethr resect use aminolevulin acid diagnost efficaci treatment outcom oral administ aminolevulin acid ala assess photodynam diagnosi pdd transurethr resect non muscl invas bladder cancer nmibc clinic practic | D000622;D001749 | T123;T121;T116;T109;T191 |
36,309,405 | effect underwat exercis salivari metabolit older person disabl underwat exercis aim prevent age maintain improv motor function improv physic function howev rehabilit effect well evalu order gain insight molecular basi rehabilit effect possibl chang salivari metabolit four older person disabl mean age year underwat exer... | D006209;D006233 | T184;T101 |
36,309,404 | circul chlamydia trachomati antigen subject alzheim diseas chlamydia pneumonia c pneumonia implic pathogenesi alzheim diseas ad chlamydi elementari reticul bodi identifi tissu afflict ad brain region electron immunoelectron microscopi wherea similar test non ad brain negat bacterium studi mice shown c pneumonia rapid p... | D002690;D000544 | T047;T048 |
36,309,403 | earli palliat care improv overal surviv patient lymphoma singl institut retrospect studi earli palliat care epc intervent patient solid tumor provid mani benefit howev studi patient hematolog malign limit data patient lymphoma conduct preliminari retrospect survey palliat care pc intervent patient lymphoma clarifi effe... | D009369;D008223 | T191 |
36,309,402 | membran activ immunomodul novel therapi infecti bacteri diseas buruli ulcer mycobacterium ulceran caus necrot skin diseas buruli ulcer bu character format subcutan lesion immunosuppress thought mediat virul factor mycolacton sinc earli bu lesion typic painless patient often seek standard oral antibiot therapi advanc st... | D054312;D019911 | T047;T007 |
36,309,401 | chase hippo implic yap taz express pregnanc associ breast cancer tumorigenesi hippo pathway molecular pathway recent associ tumorigenesi metastasi drug resist pregnanc associ breast cancer pabc common malign diagnos gestat howev molecular mechan under pabc larg unknown aim present studi evalu hippo pathway transduc taz... | D048868;D001943 | T123;T191;T116 |
36,309,400 | complet respons nivolumab resect adenocarcinoma nos parotid gland origin lung metastasi salivari gland adenocarcinoma otherwis specifi nos classifi classif head neck tumor malign neoplasm without histolog featur characterist cancer type japan nation health insur program began cover nivolumab march treatment patient rec... | D000230;D012468;D008175;D006258 | T191 |
36,309,399 | three dimension laparoscopi lc versus minilaparotomi mc cholecystectomi prospect random studi three dimension laparoscopi lap recent innov surgeri lap rare use cholecystectomi lc prospect studi assess advantag disadvantag lc versus minilaparotomi mc cholecystectomi | D017081;D010535 | T061;T060 |
36,309,398 | interferon gamma releas assay result reliabl screen latent tuberculosi antineutrophil cytoplasm antibodi associ vascul studi investig correl ex vivo interferon gamma ifn gamma product use ifn gamma releas assay igra antineutrophil cytoplasm antibodi associ vascul aav activ assess birmingham vascul activ score bvas aav ... | D055985;D056648 | T047 |
36,309,397 | clinicopatholog prognost factor determin outcom treatment gastric cancer surgeri purpos studi examin impact clinicopatholog prognost factor tumor resect periop complic year surviv rate patient gastric cancer treat surgic | D013274 | T191 |
36,309,396 | effect methylsulfonylmethan uvb induc skin damag experiment studi mous model skin protect bodi ultraviolet ray extern factor various studi conduct identifi method prevent skin age damag investig protect effect methylsulfonylmethan msm studi hairless mous model use | D014466;D015595 | T033;T070;T042 |
36,309,395 | prospect studi regard efficaci safeti bntb vaccin patient solid malign undergo system chemotherapi prospect evalu efficaci safeti bntb vaccin solid cancer patient undergo system chemotherapi n | D000086382;D009369;D014612 | T121;T129;T116;T067;T191;T047 |
36,309,394 | profit analysi minim invas approach surgic treatment spinal burst fractur regard surgic treatment incomplet burst fractur spine optim standard procedur establish previous studi focus radiolog surgic outcom paramet literatur elucid econom aspect various surgic treatment option detail yet studi aim investig whether open ... | D016103;D018460 | T037 |
36,309,393 | factor predict wors outcom asian cohort patient bronchiectasi bronchiectasi long neglect unlik chronic obstruct pulmonari diseas copd asthma recent clinic trial shown long term use azithromycin erythromycin reduc exacerb non cystic fibrosi non cf bronchiectasi activ tri treat patient suscept sever status | D001987;D029424 | T047 |
36,309,392 | balneotherapi complementari non pharmacolog approach non inflammatori complaint system lupus erythematosus pilot studi despit remiss low diseas activ non inflammatori complaint like exhaust fatigu pain persist signific proport patient system lupus erythematosus sle consider impact health relat qualiti life studi evalu ... | D008180;D001452 | T061;T047 |
36,309,391 | ca reduct month treatment prognost factor local advanc pancreat cancer carbohydr antigen ca level may aid determin subsequ treatment patient unresect local advanc pancreat cancer lapc treat chemotherapi howev relationship time magnitud ca chang clinic outcom remain unclear studi conduct identifi time magnitud ca chang ... | D018395;D010190 | T129;T191;T109 |
36,309,390 | primari osteosarcoma patient year age case seri literatur review littl known clinic characterist older patient year age primari osteosarcoma due rariti aim understand clinic characterist patient order make appropri diagnosi provid treatment | D012516;D001859 | T191 |
36,309,389 | barthel index predict postop complic elder patient undergo abdomin surgeri prospect singl center studi barthel index katz index use assess physic function status patient prospect evalu relationship barthel katz indic postop complic older patient undergo gastrointestin surgeri | D011183 | T046 |
36,309,388 | fc receptor express prognost factor patient non small cell lung cancer neonat fc receptor fcrn major histocompat class like molecul respons transfer passiv humor immun mother newborn recent research reveal fcrn involv antigen present humor immun antitumor immun various type cancer lung colon breast lung cancer lead cau... | D002289;D008175 | T191 |
36,309,387 | chloroquin combin rapamycin arrest tumor growth patient deriv orthotop xenograft pdox mous model dedifferenti liposarcoma dedifferenti liposarcoma ddls type soft tissu sarcoma poor prognosi due distant metastasi resist chemotherapi antimalari drug chloroquin cq induc apoptosi cancer cell cq combin rapamycin rapa mtor i... | D001859;D002738;D008080;D012509;D020123 | T121;T191;T195;T109 |
36,309,386 | studi therapeut effect losartan sarcopenia base fxbn rat age model sarcopenia age relat diseas muscl mass strength mark reduc effect treatment angiotensin ii receptor antagonist losartan report effect aim evalu therapeut effect losartan sarcopenia explor under mechan | D055948;D009135 | T047 |
36,309,385 | high express pregnanc specif beta glycoprotein associ poor gastric cancer prognosi pregnanc specif beta glycoprotein psg member immunoglobulin superfamili associ carcinoembryon antigen report high express varieti cancer howev role psg gastric cancer remain unclear aim studi examin clinic signific function role psg gast... | D013274 | T191 |
36,309,384 | select bodi composit paramet analysi base bioelectr imped patient oper gastrointestin cancer bioelectr imped analysi method evalu bodi composit use assess nutrit status cancer patient analysi indic may help predict clinic cours aim studi evalu follow bodi composit paramet fat mass fm fat free mass ffm skelet muscl mass... | D001823;D005770 | T032;T191 |
36,309,383 | surviv analysi use covid death mean imput codmi algorithm first clinic applic radiat oncolog report long term surviv result trimod approach local advanc rectal cancer larc covid era herein illustr clinic applic covid death mean imput codmi algorithm larc patient covid infect | D018787;D000086382 | T047;T091;T067 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.